Option chain shows key data for Kadimastem's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Kadimastem.

Kadimastem (OTC:KMSTF) Stock, Option Chain

Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.

Kadimastem Ltd

Small Cap

Press Releases

Kadimastem Calls for a Special General Meeting of Shareholders to Approve the Merger with NLS

NLS Pharmaceutics Announces the Launch of a Preclinical Program for Mazindol ER in the Treatment of Fentanyl Dependence

KMSTF

NLSP

NLSPW

Kadimastem

Comments

Kadimastem

Kadimastem (KMSTF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga